Sciomics is active in the early-phase development of novel diagnostic means for precision medicine with a focus on cancer as well as organ failure. These activities are based on an immunobased platform for highly multiplex protein analysis developed by the founders at the German Cancer Research Center (DKFZ) during the past 15 years.
In addition to the internal development activities in the field of organ failure and cancer, Sciomics offers multiplex protein analysis services for protein expression profiling, combined phosphorylation and protein analysis, drug target and biomarker discovery as well as custom antibody microarray production.
scioPhospo & scioUbi
Immunobased protein analysis and phosphorylation or ubiquitinylation status profiling for a variety of different sample types
Im Neuenheimer Feld 583
Phone: +49 6221 42948-30
Get in contact with German companies in 3 easy steps! With one single question you can reach all relevant German Pavilion exhibitors of your selected industrial branch.
Click here if you notice an image that violates copyright or privacy rights.